Ειδήσεις: UNITED THERAPEUTICS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 10:24 defenseworld.net

Traders Purchase Large Volume of United Therapeutics Call Options (NASDAQ:UTHR)

United Therapeutics options trading insider sales COO Benkowitz CEO Rothblatt call options

31/03 08:10 defenseworld.net

United Therapeutics (NASDAQ:UTHR) Shares Gap Up on Analyst Upgrade

United Therapeutics stock surge analyst upgrade price target trading volume TD Cowen

30/03 14:19 investing.com

United Therapeutics stock surges on positive drug trial results

United Therapeutics stock surge drug trial pulmonary hypertension biotech investor confidence

28/03 10:07 defenseworld.net

United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares

United Therapeutics Martine Rothblatt insider sale SEC filing market cap P/E ratio

26/03 10:39 defenseworld.net

E. Ohman J or Asset Management AB Invests $741,000 in United Therapeutics Corporation $UTHR

Asset Management United Therapeutics biotech 13F filing investment $741k

24/03 19:18 defenseworld.net

United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares

United Therapeutics Martine Rothblatt share sale SEC filing stock ownership $5 million

20/03 10:26 defenseworld.net

United Therapeutics (NASDAQ:UTHR) CEO Sells $5,072,050.00 in Stock

United Therapeutics CEO divestment Martine Rothblatt stock sale SEC filing market cap

20/03 10:26 defenseworld.net

United Therapeutics (NASDAQ:UTHR) CEO Sells $5,072,050.00 in Stock

United Therapeutics CEO divestment Martine Rothblatt stock sale SEC filing market cap

Loading...